Garrett Vygantas, MD, MBA is a founding Managing Partner of Riverine Ventures, a life science and healthcare dedicated venture capital firm. Trained as a physician and an experienced entrepreneur, Garrett provides strategic direction and valuable clinical and commercial networks as a Board Member or Advisor to AEye Health, ArtiSight, Circularis, Corsair Pharma, Eliksa Therapeutics, Endotronix, Exo Imaging, HealthBridge, Inflammatix, KeifeRx and Pieces Technologies. His previous investments include Aptinyx (NASDAQ:APTX), Doctor on Demand (acq. by Grand Rounds), Health Scholars, Gauss Surgical (acq. by Stryker, NYSE: SYK) Level Ex (acq. by Brainlab), MediBeacon, Mediphage, Paradigm Cancer Diagnostics (acq. by Exact Sciences, NASDAQ:EXAS), SilverCloud (acq. by AmWell, NYSE:AMWL), Spect, Stem Inc (NYSE: STEM) and Visibly.
With over 20 years, Garrett’s expertise spans healthcare, medtech, digital health and biopharma investing and operations. He has invested on behalf of OSF Ventures, Jump Capital and Burrill & Co. He was the founding CEO of TherOptix, NewBridge Pharmaceuticals and Mitre Medical. At NewBridge, he and his team raised over $60M in financing and created $470M in nominal value. Earlier in his career Garrett helped launch Lucentis at Genentech and worked on the healthcare investment banking team at Cowen & Company. He earned his MD /MBA degree from Georgetown University and completed his residency at the University of Pennsylvania. He is a Kauffman Fellow and Mentor at the Center for Venture Education and has served on numerous not-for-profit Boards.
This will close in 0 seconds
Scott Robert Lancaster, MD, MBA is a venture capitalist, board certiﬁed diagnostic radiologist and real estate entrepreneur with proven success in clinical medicine, practice management, corporate leadership and contract negotiations. His ability to apply business theory and systems thinking to the healthcare investment arena directly impacts the quadruple aim of healthcare and represents a balance of clinical, economic and humanistic factors - all in the interest of creating both immediate and future shared value.
As co-lead and clinical director of Spectrum Health Ventures ($100M venture arm of Spectrum Health System), Scott led investments in Arivale, Gauss Surgical (acquired by Stryker), Ciitizen (acquired by Invitae) and Vynca. As Managing Director and Chief Investment Ofﬁcer for The 4100 Group, Inc. he has led investments across all asset classes in The 4100 Group’s permanent capital vehicle.Over a 18+ year career as a practicing radiologist at Advanced Radiology Services, he served as the longtime clinical director of musculoskeletal imaging at Spectrum Health and was transformative in implementing musculoskeletal ultrasound as a diagnostic tool in clinical practice. At Advanced Radiology Services, he served as a multi-year board director, practice vice president and president of the Advanced Radiology Services Foundation.
Dr. Lancaster and his wife Maggie, the CEO of the Grand Rapids Children’s Museum, have been heavily involved in the non-proﬁt sector throughout West Michigan at Spectrum Health, the Grand Rapids Children’s Museum, the Grand Rapids Public Museum, Make-A-Wish Foundation, CASA and Family Futures.
This will close in 0 seconds